- “Pyrimethamine Tablets” already exists in your wishlist
In Stock
Olmesartan + Amlodipine Tablets
Olmesartan + Amlodipine Tablets 20mg + 5mg | Cardiac / Hypertension
- Product Form: Raw Powder / API
- Not for direct consumer use
- For qualified buyers, formulation, compounding, R&D, and regulated business use only
- COA/MSDS available upon request
- Final sale depends on buyer country import regulations
Disclaimer: Products listed on this website are intended for qualified business buyers, research, formulation, compounding, or regulated pharmaceutical use only. Products are not intended for direct consumer use. Import permission, registration, customs clearance, and local regulatory compliance are the responsibility of the buyer in their respective country.
Description
Product Introduction
This document provides a concise, practical summary of the fixed-dose combination of Olmesartan Medoxomil 20 mg and Amlodipine 5 mg. This combined formulation is commonly used for the management of essential hypertension when monotherapy is insufficient or when a complementary mechanism of action is desired. The combination pairs an angiotensin II receptor blocker (ARB) with a dihydropyridine calcium channel blocker (CCB) to produce additive blood-pressure lowering through complementary pathways.
Uses
Primary indication: Management of hypertension (high blood pressure). Specific uses include: – patients whose blood pressure is not controlled on monotherapy with either an ARB or a CCB; – patients who are expected to benefit from dual blockade of vascular tone via the renin–angiotensin system and calcium-channel mediated vasodilation.
Benefits
Key benefits of the combination: – Improved blood pressure control: additive BP reduction compared with either agent alone. – Complementary mechanisms: ARB reduces vasoconstriction and sodium retention while CCB reduces peripheral vascular resistance. – Once-daily dosing: convenient regimen that can improve adherence. – Reduced single-agent side effects at lower doses: combining lower doses may lower the risk of some dose-related adverse effects compared with high-dose monotherapy.
Side Effects
Common side effects: – Dizziness or lightheadedness (especially after the first dose or on dose escalation) due to blood-pressure lowering. – Peripheral edema (swelling of feet/ankles) — primarily associated with amlodipine. – Headache and flushing — more common with vasodilators. – Fatigue or somnolence.
Less common but important adverse effects: – Hypotension (excessive blood-pressure drop) particularly in volume-depleted patients. – Renal function changes (rise in serum creatinine) — monitor renal function in patients with renal disease, heart failure, or those taking diuretics. – Hyperkalemia — a risk with ARBs when combined with potassium supplements, potassium-sparing diuretics, or in renal impairment. – Rare: angioedema or hypersensitivity reactions — seek emergency care for facial or throat swelling, difficulty breathing, or rash.
Safety Advice
Important safety points: – Pregnancy: ARBs (including olmesartan) are contraindicated in pregnancy (can cause fetal injury and death). Women of childbearing potential should use reliable contraception and inform their prescriber immediately if pregnancy is planned or suspected. – Breastfeeding: limited data. Consult the prescriber; alternative agents with established safety may be preferred. – Renal impairment: monitor renal function and electrolytes (serum creatinine, potassium) periodically; dose adjustment may be required. – Elderly: start at lower doses and monitor for orthostatic hypotension and renal function. – Avoid abrupt withdrawal: suddenly stopping antihypertensive therapy can lead to rebound hypertension; any change should be made under medical supervision.
How It Works
Olmesartan Medoxomil (ARB): Olmesartan is converted in the body to its active form and selectively blocks the angiotensin II type 1 (AT1) receptors. Blocking AT1 receptors prevents angiotensin II–mediated vasoconstriction, sodium retention and aldosterone release, leading to vasodilation and lower blood pressure.
Amlodipine (Dihydropyridine CCB): Amlodipine inhibits L-type calcium channels in vascular smooth muscle, causing arterial vasodilation and reduced peripheral vascular resistance. This lowers blood pressure and may improve coronary blood flow in patients with ischemic heart disease.
Together, the two drugs provide additive antihypertensive effects by decreasing vascular resistance through distinct mechanisms — blockade of angiotensin II signaling and calcium entry into vascular smooth muscle.
How to Use
General dosing and administration: – Usual regimen: one tablet containing olmesartan 20 mg + amlodipine 5 mg orally once daily. – Timing: can be taken with or without food at the same time each day to maintain consistent blood levels. – Missed dose: if you miss a dose, take it as soon as you remember unless it is almost time for the next dose. Do not double the next dose. – Initiation and titration: therapy should be started and adjusted by a healthcare professional based on baseline blood pressure, comorbidities, and tolerability. Dose adjustments or switching to alternative doses may be required for specific patients.
Quick Tips
-
Take the medicine at the same time every day to improve adherence.
-
Measure and record blood pressure regularly during the first weeks after starting or changing dose.
-
Avoid standing up quickly to reduce the risk of dizziness or lightheadedness.
-
Limit alcohol consumption while on therapy because alcohol can enhance blood-pressure lowering and dizziness.
-
If peripheral edema occurs and is bothersome, consult your prescriber; they may adjust therapy (reduce amlodipine dose or consider alternative strategies).
-
Carry a list of your medications (including over-the-counter drugs and supplements) and share it with any healthcare provider.
Drug Interactions
Notable and clinically relevant interactions to watch for:
When to Contact a Healthcare Provider
Seek medical advice promptly if any of the following occur: – fainting, severe dizziness, or symptoms of very low blood pressure; – signs of angioedema (swelling of face, lips, tongue, throat) or severe allergic reaction; – sudden decrease in urine output or signs of worsening kidney function; – severe or persistent chest pain or shortness of breath; – persistent or worsening peripheral edema or severe leg swelling.
Monitoring and Baseline Tests
Before starting and during treatment, consider: – baseline blood pressure and periodic BP checks; – serum electrolytes (especially potassium) and renal function (serum creatinine/BUN); – liver function tests if clinically indicated; – review of concomitant medications for potential interactions.
Note: This document is for informational purposes only. It does not replace medical advice. For personalized recommendations, dosing adjustments, or questions about interactions with your other medicines or medical conditions, consult a licensed healthcare provider or pharmacist.
| Product Name | Olmesartan + Amlodipine Tablets |
| Category | All Medicines, Cardiac / Hypertension |
| Form | Raw Powder |
| Grade | As per available specification |
| Documents | COA, MSDS, Invoice, Packing List |
| Packing | As per order quantity |
| MOQ | On request |
| Shipment | Air cargo / courier / buyer-approved route |
| Use | B2B, formulation, compounding, research & qualified buyer supply |
| Disclaimer | Subject to buyer country regulations |
Additional information
| Strength | 20mg + 5mg |
|---|
Customer Reviews
Only logged in customers who have purchased this product may leave a review.
